Market data loadingS&P 500--NASDAQ--Data as of latest ETNo timestamp

Oscar Health, Inc. (OSCR) Financial Statements

Oscar Health, Inc. (OSCR) reported trailing twelve-month revenue of $15.3B (up 42.8% year on year) and net income of $550.7M as of 2026-06-30, according to EquiReason's reading of its SEC filings. Free cash flow over the same period: $4.4B.

Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason

OSCROscar Health, Inc.Follow OSCR — free
Healthcare Plans · Healthcare
—
Price chart with a free account
Market cap
9.6B
P/E TTM
18.5
Dividend yield
—
52-week
—
Next earnings
5 Nov, in 12 days

Fiscal-year columns end in the month shown. The current fiscal year appears once its annual report is filed; until then TTM = the last four reported quarters, to Jun 26.

LineFY2021
Dec 21
FY2022
Dec 22
FY2023
Dec 23
FY2024
Dec 24
FY2025
Dec 25
TTM
Jun 26
Trend
Revenue1.843.965.869.1811.7015.32
Operating income-0.54-0.59-0.240.06-0.400.63
Pre-tax income-0.57-0.61-0.270.03-0.440.59
Income tax0.00-0.000.000.010.010.04
Net income-0.57-0.61-0.270.03-0.440.55
Diluted EPS ($)-3.20-2.85-1.220.10-1.691.67
Diluted shares (bn)0.1790.2120.2220.2660.262—

USD billions · SEC XBRL

Oscar Health, Inc. — questions

What is Oscar Health, Inc.'s revenue?
$15.3B over the twelve months to 2026-06-30, up 42.8% year on year, from its 10-Q and 10-K filings.
What is Oscar Health, Inc.'s net income?
$550.7M over the twelve months to 2026-06-30.
What is Oscar Health, Inc.'s free cash flow?
$4.4B over the twelve months to 2026-06-30.
What are Oscar Health, Inc.'s diluted earnings per share?
$1.67 over the twelve months to 2026-06-30.

Every figure on this page comes from Oscar Health, Inc.'s own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.

How these figures are read: methodology · EquiReason.